5445782026-01-012026-03-315445782026-03-315445782025-03-315445782025-04-012026-03-315445782026-01-012026-03-31in-capmkt:OtherExpenses1Member5445782025-04-012026-03-31in-capmkt:OtherExpenses1Member5445782026-03-31OtherNoncurrentFinancialAssetsDomain15445782026-03-31OtherNoncurrentAssetsDomain15445782026-03-31OtherNoncurrentAssetsDomain25445782026-03-31OtherCurrentFinancialAssetsDomain15445782026-03-31OtherCurrentAssetsDomain15445782026-03-31OtherNoncurrentFinancialLiabilitiesDomain15445782026-03-31OtherCurrentFinancialLiabilitiesDomain15445782026-03-31OtherCurrentFinancialLiabilitiesDomain25445782026-03-31OtherCurrentLiabilitiesDomain15445782026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15445782025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15445782026-01-012026-03-31RelatedPartyTransactionDomain15445782025-12-31RelatedPartyTransactionDomain15445782026-03-31RelatedPartyTransactionDomain15445782026-01-012026-03-31RelatedPartyTransactionDomain25445782025-12-31RelatedPartyTransactionDomain25445782026-03-31RelatedPartyTransactionDomain25445782026-01-012026-03-31RelatedPartyTransactionDomain35445782025-12-31RelatedPartyTransactionDomain35445782026-03-31RelatedPartyTransactionDomain35445782026-01-012026-03-31RelatedPartyTransactionDomain45445782025-12-31RelatedPartyTransactionDomain45445782026-03-31RelatedPartyTransactionDomain45445782026-01-012026-03-31RelatedPartyTransactionDomain55445782025-12-31RelatedPartyTransactionDomain55445782026-03-31RelatedPartyTransactionDomain55445782026-01-012026-03-31RelatedPartyTransactionDomain65445782025-12-31RelatedPartyTransactionDomain65445782026-03-31RelatedPartyTransactionDomain65445782026-01-012026-03-31RelatedPartyTransactionDomain75445782025-12-31RelatedPartyTransactionDomain75445782026-03-31RelatedPartyTransactionDomain75445782026-01-012026-03-31RelatedPartyTransactionDomain85445782025-12-31RelatedPartyTransactionDomain85445782026-03-31RelatedPartyTransactionDomain85445782026-01-012026-03-31RelatedPartyTransactionDomain95445782025-12-31RelatedPartyTransactionDomain95445782026-03-31RelatedPartyTransactionDomain95445782026-01-012026-03-31RelatedPartyTransactionDomain105445782025-12-31RelatedPartyTransactionDomain105445782026-03-31RelatedPartyTransactionDomain105445782026-01-012026-03-31RelatedPartyTransactionDomain115445782025-12-31RelatedPartyTransactionDomain115445782026-03-31RelatedPartyTransactionDomain115445782026-01-012026-03-31RelatedPartyTransactionDomain125445782025-12-31RelatedPartyTransactionDomain125445782026-03-31RelatedPartyTransactionDomain125445782026-01-012026-03-31RelatedPartyTransactionDomain135445782025-12-31RelatedPartyTransactionDomain135445782026-03-31RelatedPartyTransactionDomain135445782026-01-012026-03-31RelatedPartyTransactionDomain145445782025-12-31RelatedPartyTransactionDomain145445782026-03-31RelatedPartyTransactionDomain145445782026-01-012026-03-31RelatedPartyTransactionDomain155445782025-12-31RelatedPartyTransactionDomain155445782026-03-31RelatedPartyTransactionDomain155445782026-01-012026-03-31RelatedPartyTransactionDomain165445782025-12-31RelatedPartyTransactionDomain165445782026-03-31RelatedPartyTransactionDomain165445782026-01-012026-03-31RelatedPartyTransactionDomain175445782025-12-31RelatedPartyTransactionDomain175445782026-03-31RelatedPartyTransactionDomain175445782026-01-012026-03-31RelatedPartyTransactionDomain185445782025-12-31RelatedPartyTransactionDomain185445782026-03-31RelatedPartyTransactionDomain185445782026-01-012026-03-31RelatedPartyTransactionDomain195445782025-12-31RelatedPartyTransactionDomain195445782026-03-31RelatedPartyTransactionDomain195445782026-01-012026-03-31RelatedPartyTransactionDomain205445782025-12-31RelatedPartyTransactionDomain205445782026-03-31RelatedPartyTransactionDomain205445782026-01-012026-03-31RelatedPartyTransactionDomain215445782025-12-31RelatedPartyTransactionDomain215445782026-03-31RelatedPartyTransactionDomain215445782026-01-012026-03-31RelatedPartyTransactionDomain225445782025-12-31RelatedPartyTransactionDomain225445782026-03-31RelatedPartyTransactionDomain225445782026-01-012026-03-31RelatedPartyTransactionDomain235445782025-12-31RelatedPartyTransactionDomain235445782026-03-31RelatedPartyTransactionDomain235445782026-01-012026-03-31RelatedPartyTransactionDomain245445782025-12-31RelatedPartyTransactionDomain245445782026-03-31RelatedPartyTransactionDomain245445782026-01-012026-03-31RelatedPartyTransactionDomain255445782025-12-31RelatedPartyTransactionDomain255445782026-03-31RelatedPartyTransactionDomain255445782026-01-012026-03-31RelatedPartyTransactionDomain265445782025-12-31RelatedPartyTransactionDomain265445782026-03-31RelatedPartyTransactionDomain265445782026-01-012026-03-31RelatedPartyTransactionDomain275445782025-12-31RelatedPartyTransactionDomain275445782026-03-31RelatedPartyTransactionDomain275445782026-01-012026-03-31RelatedPartyTransactionDomain285445782025-12-31RelatedPartyTransactionDomain285445782026-03-31RelatedPartyTransactionDomain285445782026-01-012026-03-31RelatedPartyTransactionDomain295445782025-12-31RelatedPartyTransactionDomain295445782026-03-31RelatedPartyTransactionDomain295445782026-01-012026-03-31RelatedPartyTransactionDomain305445782025-12-31RelatedPartyTransactionDomain305445782026-03-31RelatedPartyTransactionDomain305445782026-01-012026-03-31RelatedPartyTransactionDomain315445782025-12-31RelatedPartyTransactionDomain315445782026-03-31RelatedPartyTransactionDomain315445782026-01-012026-03-31RelatedPartyTransactionDomain325445782025-12-31RelatedPartyTransactionDomain325445782026-03-31RelatedPartyTransactionDomain325445782026-01-012026-03-31RelatedPartyTransactionDomain335445782025-12-31RelatedPartyTransactionDomain335445782026-03-31RelatedPartyTransactionDomain335445782026-01-012026-03-31RelatedPartyTransactionDomain345445782025-12-31RelatedPartyTransactionDomain345445782026-03-31RelatedPartyTransactionDomain345445782026-01-012026-03-31RelatedPartyTransactionDomain355445782025-12-31RelatedPartyTransactionDomain355445782026-03-31RelatedPartyTransactionDomain355445782026-01-012026-03-31RelatedPartyTransactionDomain365445782025-12-31RelatedPartyTransactionDomain365445782026-03-31RelatedPartyTransactionDomain365445782026-01-012026-03-31RelatedPartyTransactionDomain375445782025-12-31RelatedPartyTransactionDomain375445782026-03-31RelatedPartyTransactionDomain375445782026-01-012026-03-31RelatedPartyTransactionDomain385445782025-12-31RelatedPartyTransactionDomain385445782026-03-31RelatedPartyTransactionDomain385445782026-01-012026-03-31RelatedPartyTransactionDomain395445782025-12-31RelatedPartyTransactionDomain395445782026-03-31RelatedPartyTransactionDomain395445782026-01-012026-03-31RelatedPartyTransactionDomain405445782025-12-31RelatedPartyTransactionDomain405445782026-03-31RelatedPartyTransactionDomain405445782026-01-012026-03-31RelatedPartyTransactionDomain415445782025-12-31RelatedPartyTransactionDomain415445782026-03-31RelatedPartyTransactionDomain415445782026-01-012026-03-31RelatedPartyTransactionDomain425445782025-12-31RelatedPartyTransactionDomain425445782026-03-31RelatedPartyTransactionDomain425445782026-01-012026-03-31RelatedPartyTransactionDomain435445782025-12-31RelatedPartyTransactionDomain435445782026-03-31RelatedPartyTransactionDomain435445782026-01-012026-03-31RelatedPartyTransactionDomain445445782025-12-31RelatedPartyTransactionDomain445445782026-03-31RelatedPartyTransactionDomain445445782026-01-012026-03-31RelatedPartyTransactionDomain455445782025-12-31RelatedPartyTransactionDomain455445782026-03-31RelatedPartyTransactionDomain455445782026-01-012026-03-31RelatedPartyTransactionDomain465445782025-12-31RelatedPartyTransactionDomain465445782026-03-31RelatedPartyTransactionDomain465445782026-01-012026-03-31RelatedPartyTransactionDomain475445782025-12-31RelatedPartyTransactionDomain475445782026-03-31RelatedPartyTransactionDomain475445782026-01-012026-03-31RelatedPartyTransactionDomain485445782025-12-31RelatedPartyTransactionDomain485445782026-03-31RelatedPartyTransactionDomain485445782026-01-012026-03-31RelatedPartyTransactionDomain495445782025-12-31RelatedPartyTransactionDomain495445782026-03-31RelatedPartyTransactionDomain495445782026-01-012026-03-31RelatedPartyTransactionDomain505445782025-12-31RelatedPartyTransactionDomain505445782026-03-31RelatedPartyTransactionDomain505445782026-01-012026-03-31RelatedPartyTransactionDomain515445782025-12-31RelatedPartyTransactionDomain515445782026-03-31RelatedPartyTransactionDomain515445782026-01-012026-03-31RelatedPartyTransactionDomain525445782025-12-31RelatedPartyTransactionDomain525445782026-03-31RelatedPartyTransactionDomain525445782026-01-012026-03-31RelatedPartyTransactionDomain535445782025-12-31RelatedPartyTransactionDomain535445782026-03-31RelatedPartyTransactionDomain535445782026-01-012026-03-31RelatedPartyTransactionDomain545445782025-12-31RelatedPartyTransactionDomain545445782026-03-31RelatedPartyTransactionDomain545445782026-01-012026-03-31RelatedPartyTransactionDomain555445782025-12-31RelatedPartyTransactionDomain555445782026-03-31RelatedPartyTransactionDomain555445782026-01-012026-03-31RelatedPartyTransactionDomain565445782025-12-31RelatedPartyTransactionDomain565445782026-03-31RelatedPartyTransactionDomain565445782026-01-012026-03-31RelatedPartyTransactionDomain575445782025-12-31RelatedPartyTransactionDomain575445782026-03-31RelatedPartyTransactionDomain575445782026-01-012026-03-31RelatedPartyTransactionDomain585445782025-12-31RelatedPartyTransactionDomain585445782026-03-31RelatedPartyTransactionDomain585445782026-01-012026-03-31RelatedPartyTransactionDomain595445782025-12-31RelatedPartyTransactionDomain595445782026-03-31RelatedPartyTransactionDomain595445782026-01-012026-03-31RelatedPartyTransactionDomain605445782025-12-31RelatedPartyTransactionDomain605445782026-03-31RelatedPartyTransactionDomain605445782026-01-012026-03-31RelatedPartyTransactionDomain615445782025-12-31RelatedPartyTransactionDomain615445782026-03-31RelatedPartyTransactionDomain615445782026-01-012026-03-31RelatedPartyTransactionDomain625445782025-12-31RelatedPartyTransactionDomain625445782026-03-31RelatedPartyTransactionDomain625445782026-01-012026-03-31RelatedPartyTransactionDomain635445782025-12-31RelatedPartyTransactionDomain635445782026-03-31RelatedPartyTransactionDomain635445782026-01-012026-03-31RelatedPartyTransactionDomain645445782025-12-31RelatedPartyTransactionDomain645445782026-03-31RelatedPartyTransactionDomain645445782026-01-012026-03-31RelatedPartyTransactionDomain655445782025-12-31RelatedPartyTransactionDomain655445782026-03-31RelatedPartyTransactionDomain655445782026-01-012026-03-31RelatedPartyTransactionDomain665445782025-12-31RelatedPartyTransactionDomain665445782026-03-31RelatedPartyTransactionDomain665445782026-01-012026-03-31RelatedPartyTransactionDomain675445782025-12-31RelatedPartyTransactionDomain675445782026-03-31RelatedPartyTransactionDomain675445782026-01-012026-03-31RelatedPartyTransactionDomain685445782025-12-31RelatedPartyTransactionDomain685445782026-03-31RelatedPartyTransactionDomain685445782026-01-012026-03-31AuditorDomain15445782026-03-31Statement15445782026-01-012026-03-31Statement15445782026-03-31StatementDynamic1I1Statement15445782026-03-31StatementDynamic1I2Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares544578RUBICONNOTLISTEDINE506V01022RUBICON RESEARCH LIMITEDMain BoardEquity2025-04-012026-03-312026-05-292026-05-22INRMillionsQuarterlyFourth quarterSingle segmentPharmaceutical2026-05-2914:30:002026-05-2916:10:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2025-10-16https://www.rubicon.co.in/pdf/Related-Party-Transactions-Policy.pdftrue1falseThere was a default on loans. Further, the Company were no debt securities issued by the Company.2026-01-012026-03-31AuditedStandalone389878000035810000393459000012281500000-6703000042738000053960000101660000124862000029927400009418500000941850000291450000-4980000024165000007002000000000700200000-37000069983000016509000014.254.2004.254.2The Audited Financial Results of the Company for the quarter and year ended March 31, 2026, including notes are available on the Company's website and on the websites of BSE and NSE. <BR> <BR> The results can be accessed at https://www.bseindia.com/xml-data/corpfiling/AttachLive/93687ba9-58de-494c-8d5f-e842103344c5.pdf2025-04-012026-03-31AuditedStandalone130608200001083200001316914000045308900000-3335800001642650000309600000377480000411431000010641350000252779000002527790000684280000-381400006461400000188165000000001881650000-8000000187365000016509000011336764000011.8311.670011.8311.67Other Expenses1248620000Other Expenses41143100004061300000255440000001015600001060000004338900000395100004772800009506800005348000018647000056099900003478200000071343400009177900001592640000031950000099642700000702570000141450400000019755030000165090000133676400001353273000013532730000143023000000010756000015377900001163600000016541500001163460000572000002561390000261859000057145000043535000001910300001909000045300000456815000000622230000019755030000Other financial assets477280000Non Current Tax Assets (net)65970000Other non-current assets120500000Other current financial assets319500000Other current assets702570000Lease Liabilities107560000Lease Liabilities59080000Other current financial liabilities512370000Other current liabilities191030000309600000-899020000-198857000006258000000-959700000752440000011959000003774800000013890000801200000-5440000080000929400003832000016711000000995000012700000-119863000013291600000009420200000387140000000211200000000236000019455300000000000000000897400007335500000080000726500000-1470150000-27179000000047604800000007175000001247470000277439000061850000308000027321000000296717000063641000022870000659280000258510000917790000Items that will not be reclassified to profit or loss-490000-490000Items that will not be reclassified to profit or loss-10690000-10690000-120000-269000000-370000-8000000Rubicon Research Limited******Pratibha Pilgaonkar******Managing DirectorRemuneration17600000Approved887000000Rubicon Research Limited******Parag Sancheti******Executive Director and Chief Executive OfficerRemuneration56000000Approved2223000000Rubicon Research Limited******Sumant Pilgaonkar******SMP and PromoterRemuneration17600000Approved710000000Rubicon Research Limited******Sudhir Pilgaonkar******SMP and PromoterRemuneration4000000Approved205000000Rubicon Research Limited******Surabhi Sancheti******SMP and PromoterRemuneration26400000Approved1064000000Rubicon Research Limited******Otrio Ventures Pvt Ltd.******Entity in which KMP or relatives of KMP have control or significant influencePurchase of goods or services3000000Approved167000000Rubicon Research Limited******MedOne Pharma Labs******Entity in which KMP or relatives of KMP have control or significant influenceAny other transactionLeave and License fees55000000Approved2735000000Rubicon Research Limited******AdvaGen Pharma Limited******Holding-SubsidiarySale of goods or services12000000000Approved547771000000Rubicon Research Limited******Rubicon Consumer Healthcare Private Limited******Holding-SubsidiarySale of goods or services10000000Approved569000000AdvaGen Pharma Europe OU******AdvaGen Pharma Limited******SubsidiariesSale of goods or services0Not Applicable106196000000Rubicon Research Limited******Validus Pharmaceuticals LLC******Holding-SubsidiarySale of goods or services2000000000Approved3322000000Rubicon Research Limited******Rubicon Consumer Healthcare Private Limited******Holding-SubsidiaryInterest received0Not Applicable75000000Rubicon Research Limited******Rubicon Consumer Healthcare Private Limited******Holding-SubsidiaryAny other transactionOther non-operating Income0Not Applicable60000000Rubicon Research Limited******AdvaGen Holding Inc******Holding-SubsidiaryInterest received0Not Applicable571000000Rubicon Research Limited******Rubicon Research Private Limited (Singapore)******Holding-SubsidiaryInterest received0Not Applicable23000000Rubicon Research Limited******Kia Health Tech Private Limited******Holding-SubsidiaryInterest received0Not Applicable18000000Rubicon Research Limited******Rubicon Research Australia Pty Ltd******Holding-SubsidiaryInterest received0Not Applicable22000000AdvaGen Pharma Limited******AdvaGen Holding Inc******SubsidiariesInterest received0Not Applicable1334000000AdvaGen Holding Inc******Validus Pharmaceuticals LLC******SubsidiariesInterest received0Not Applicable167000000Validus Pharmaceuticals LLC******AdvaGen Holding Inc******SubsidiariesInterest received0Not Applicable124000000AdvaGen Pharma Limited******AdvaGen Holding Inc******SubsidiariesInterest paid0Not Applicable4000000Rubicon Research Limited******Rubicon Research Canada Limited******Holding-SubsidiaryAny other transactionProduct development expenses500000000Approved23639000000Rubicon Research Limited******AdvaGen Pharma Limited******Holding-SubsidiaryAny other transactionProduct development expenses30000000Approved86000000Rubicon Research Limited******AdvaGen Pharma Limited******Holding-SubsidiaryAny other transactionOther Non-Operating Income0Not Applicable2658000000AdvaGen Pharma Limited******AIM RX3PL L.L.C******Fellow SubsidiaryPurchase of goods or services120000000Approved3003000000Validus Pharmaceuticals LLC******AIM RX3PL L.L.C******Fellow SubsidiaryPurchase of goods or services40000000Approved943000000AdvaGen Pharma Limited******AdvaGen Holding Inc******SubsidiariesAny other transactionLoan repaid0Not Applicable1066000000AdvaGen Pharma Limited******AdvaGen Holding Inc******SubsidiariesLoan0Not Applicable76342000000Loan0Repayable on or before 1st May 2028UnsecuredBusiness PurposeInterest rate: Secured Overnight Financing Rate SOFR+ 200 bps paRubicon Research Limited******AdvaGen Holding Inc******Holding-SubsidiaryAny other transactionLoan repaid by Subsidiary0Not Applicable48628000000AdvaGen Holding Inc******Validus Pharmaceuticals LLC******SubsidiaryLoan0Not Applicable8877000000Loan03 YearsUnsecuredBusiness PurposeSecured Overnight Financing Rate+ 2% paAdvaGen Holding Inc******Validus Pharmaceuticals LLC******SubsidiaryAny other transactionLoan repaid by Holding0Not Applicable8877000000AdvaGen Holding Inc******Validus Pharmaceuticals LLC******SubsidiaryAny other transactionLoan repaid by Subsidiary0Not Applicable20741000000Rubicon Research Limited******AdvaGen Holding Inc******Holding-SubsidiaryLoan0Not Applicable8974000000Rubicon Research Limited******AdvaGen Holding Inc******Holding-SubsidiaryLoan0Not Applicable03991900000AdvaGen Holding Inc******Validus Pharmaceuticals LLC******SubsidiaryLoan0Not Applicable02560500000AdvaGen Pharma Limited******AdvaGen Holding Inc******HoldingLoan0Not Applicable0399190000811090000Rubicon Research Limited******Kia Health Tech Private Limited******Holding-SubsidiaryLoan0Not Applicable050000005000000Rubicon Research Limited******Rubicon Research Private Limited (Singapore)******Holding-SubsidiaryLoan0Not Applicable075600008040000Rubicon Research Limited******Rubicon Research Australia Pty Ltd******Holding-SubsidiaryLoan0Not Applicable058300006470000Rubicon Research Limited******Rubicon Consumer Healthcare Private Limited******Holding-SubsidiaryLoan0Not Applicable02000000020000000Rubicon Research Limited******AdvaGen Holding Inc******Holding-SubsidiaryAny other transactionTrade and Other receivables0Not Applicable0143900000Rubicon Research Limited******Validus Pharmaceuticals LLC******Holding-SubsidiaryAny other transactionTrade and other payable0Not Applicable01943000020650000Rubicon Research Limited******AIM RX3PL L.L.C******Holding-SubsidiaryAny other transactionTrade and Other receivables0Not Applicable0470000470000Rubicon Research Limited******Validus Pharmaceuticals LLC******Holding-SubsidiaryAny other transactionTrade and Other receivables0Not Applicable06596000086570000Rubicon Research Limited******Rubicon Research Canada Limited******Holding-SubsidiaryAny other transactionTrade and Other Payables0Not Applicable0197620000241520000Rubicon Research Limited******Rubicon Research Canada Limited******Holding-SubsidiaryAny other transactionTrade and Other receivables0Not Applicable07045000074950000AdvaGen Pharma Limited******Advatech Bio Pharma Ltd******Fellow SubsidiaryAny other transactionTrade and Other receivables0Not Applicable0630000720000AdvaGen Pharma Limited******AdvaGen Pharma Europe Oãœ******Fellow SubsidiaryAny other transactionAdvance given0Not Applicable0905600000732890000Rubicon Research Limited******Rubicon Research Australia Pty Ltd******Holding-SubsidiaryAny other transactionTrade and Other receivables0Not Applicable057800006650000Rubicon Research Limited******Rubicon Research Private Limited (Singapore)******Holding-SubsidiaryAny other transactionTrade and Other receivables0Not Applicable029600003730000AdvaGen Pharma Limited******AdvaGen Holding Inc******HoldingAny other transactionTrade and Other receivables0Not Applicable0558000019970000AdvaGen Pharma Limited******AIM RX3PL L.L.C******Fellow SubsidiaryAny other transactionTrade and Other receivables0Not Applicable053810000104440000AdvaGen Pharma Limited******Validus Pharmaceuticals LLC******Fellow SubsidiaryAny other transactionTrade and Other receivables0Not Applicable0150000023050000AdvaGen Holding Inc******AdvaGen Pharma Limited******SubsidiaryAny other transactionTrade and Other receivables0Not Applicable0121470000116040000AdvaGen Holding Inc******Validus Pharmaceuticals LLC******SubsidiaryAny other transactionTrade and Other receivables0Not Applicable01942000016250000AdvaGen Holding Inc******AIM RX3PL L.L.C******SubsidiaryAny other transactionTrade and Other receivables0Not Applicable01285000013670000Rubicon Research Limited******Rubicon Consumer Healthcare Private Limited******Holding-SubsidiaryAny other transactionTrade and Other Payables0Not Applicable01262000012620000Rubicon Research Limited******Rubicon Consumer Healthcare Private Limited******Holding-SubsidiaryAny other transactionTrade and Other receivables0Not Applicable03580000042580000Rubicon Research Limited******AdvaGen Pharma Limited******Holding-SubsidiaryAny other transactionTrade and Other receivables0Not Applicable045013700006157590000Rubicon Research Limited******AdvaGen Holding Inc******Holding-SubsidiaryAny other transactionTrade and Others payables0Not Applicable0638000013920000Rubicon Research Limited******AdvaGen Pharma Limited******Holding-SubsidiaryAny other transactionTrade and Others payables0Not Applicable0988000013390000Rubicon Research Limited******Kia Health Tech Private Limited******Holding-SubsidiaryAny other transactionTrade and Other receivables0Not Applicable084460000152030000AdvaGen Pharma Limited******Rubicon Research Canada Limited******Fellow SubsidiaryAny other transactionTrade and Other receivables0Not Applicable0047790000Validus Pharmaceuticals LLC******AIM RX3PL L.L.C******Fellow SubsidiaryAny other transactionTrade and Others payables0Not Applicable0010020000Rubicon Research Limited******Kia Health Tech Private Limited******Holding-SubsidiaryAny other transactionSale of Asset0Not Applicable67000000Rubicon Research Limited******AdvaGen Pharma Limited******Holding-SubsidiaryAny other transactionGuarantee Given0Not Applicable012047400001868480000Rubicon Research Limited******MedOne Pharma Labs******Entity in which KMP or relatives of KMP have control or significant influenceAny other transactionDeposits Given0Not Applicable01000000013940000Rubicon Research Limited******AdvaGen Holding Inc******Fellow SubsidiaryPurchase of goods or services0Not Applicable7540000008729020000AuditedtrueDeloitte Haskins & Sells LLPtrue2027-07-31Public Issues2025-10-1650000000002026-03-31trueIndia Ratings & Research Private LimitedtruefalseAs disclosed in the Offer Document dated October 13, 2025, the Company had proposed to utilise INR 4,712.74 Million from the IPO net proceeds for identified objects by Fiscal Year 2026. As of March 31, 2026, a total amount of INR 3,236.46 Million has been utilised toward the said objects, whereby the remaining unutilised balance stands at INR 1,476.28 Million.The Board of Directors of the Company, at its meeting held today, i.e., May 29, 2026, has, based on the recommendation of the Audit Committee, approved the extension of the timeline for the utilisation of the unutilised Initial Public Offering (‘IPO’) proceeds by a period of one year, i.e., up to March 31, 2027.NADeepashree TanksaleCompany Secretary and Compliance OfficerThane2026-05-29Prepayment or scheduled repayment of all or a portion of certain outstanding borrowings availed by our Company.No modification310000000002646410000453590000The Board of Directors of the Company, at its meeting held today, i.e., May 29, 2026, has, based on the recommendation of the Audit Committee, approved the extension of the timeline for the utilisation of the unutilised Initial Public Offering (IPO) proceeds by a period of one year, i.e., up to March 31, 2027. <br></br> <br></br> The reason for delay in the deployment of the remaining proceeds refer to the stock exchange intimation submitted by the Company which can accessed at:Funding inorganic growth through unidentified acquisitions and other strategic initiatives and General corporate purposesNo modification161274000005900500001022690000The Board of Directors of the Company, at its meeting held today, i.e., May 29, 2026, has, based on the recommendation of the Audit Committee, approved the extension of the timeline for the utilisation of the unutilised Initial Public Offering (IPO) proceeds by a period of one year, i.e., up to March 31, 2027. <br></br> <br></br> The reason for deployment of the remaining proceeds refer the stock exchange intimation submitted by the Company which can accessed at: